Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Stryker Acquisition: Yes, Virginia, There Is A Market For Patient Safety
Forbes
Thursday, January 2, 2014 - 9:36am
tags:
Stryker, M&A, Patient Safety Technologies
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thursday, January 2, 2014 - 9:35am
tags:
Bristol-Myers Squibb, Roche, brain cancer, CytRx, Celldex Therapeutics, ImmunoCellular Therapeutics, Northwest Biotherapeutics, glioblastoma multiforme, nivolumab, Yervoy
China Puts the Brakes on Imports of Pfizer’s Diflucan
Wall St Cheat Sheet
Thursday, January 2, 2014 - 9:33am
tags:
China, Pfizer, Diflucan, AIDS, antifungals
4 Biggest Biotech Disasters Of 2013
Forbes
Wednesday, January 1, 2014 - 11:41am
tags:
Amarin, Vascepa, Ariad Pharmaceuticals, Iclusig, Celsion, ThermoDox, IPI-145, Infinity Pharmaceuticals
Gilead Hepatitis C Pill Leads 27 New U.S. Drug Approvals
Bloomberg
Wednesday, January 1, 2014 - 11:02am
tags:
Gilead, hepatitis C, drug approvals, Sovaldi
Justice delays health law's birth control mandate
Yahoo/AP
Wednesday, January 1, 2014 - 11:01am
tags:
Supreme Court, Affordable Care Act, contraceptives
Lupin up on U.S. regulatory approval for generic drug
Yahoo/Reuters
Wednesday, January 1, 2014 - 10:49am
tags:
Lupin, generics, niacin
Biotech 2013 By the Numbers: A Blockbuster Year
TheStreet.com
Wednesday, January 1, 2014 - 10:47am
tags:
biotech
Biotech M&A Growth Trend To Continue
Seeking Alpha
Tuesday, December 31, 2013 - 11:47am
tags:
biotech, M&A
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Fierce Biotech
Tuesday, December 31, 2013 - 11:42am
tags:
Argos, IPOs, Dendreon, AGS-003, personalized medicine, renal cell carcinoma
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Fierce Biotech
Tuesday, December 31, 2013 - 11:40am
tags:
dry eye disease, Third Rock, IPOs, Eleven Biotherapeutics
Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Pharmabiz.com
Tuesday, December 31, 2013 - 11:36am
tags:
FDA, Veloxis, Envarsus, kidney translants
Pipeline Setback at Can-Fite BioPharma, Shares Down
Yahoo/Zacks.com
Tuesday, December 31, 2013 - 11:31am
tags:
Can-Fite BioPharma, CF101
China halts imports of Pfizer drug on paperwork glitch
Reuters
Tuesday, December 31, 2013 - 10:36am
tags:
China, Pfizer
Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240M
Fierce Pharma
Tuesday, December 31, 2013 - 10:32am
tags:
Saphris, Merck, layoffs, drug reps, Forest Labs
Cellular Therapy: Representing The Paradigm Shift In Healthcare
Seeking Alpha
Tuesday, December 31, 2013 - 10:26am
tags:
NeoStem, stem cells, Baxter International, AMR-001
Stryker to buy Patient Safety Technologies for $120 mln
Yahoo/Reuters
Tuesday, December 31, 2013 - 10:19am
tags:
Patient Safety Technologies, M&A, Stryker, devices
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tuesday, December 31, 2013 - 10:17am
tags:
Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly
Understanding Zerenex's Patent Protection And Latest Issuance
Seeking Alpha
Tuesday, December 31, 2013 - 10:13am
tags:
Zerenex, patents, Keryx
Jazz, Valeant Join Drug Makers' Q4 Merger Rush
Investors.com
Monday, December 30, 2013 - 7:26pm
tags:
Valeant Pharmaceuticals, Jazz Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.